Literature DB >> 17981205

The expansion and maintenance of antigen-selected CD8(+) T cell clones.

Douglas T Fearon1.   

Abstract

The biological purpose of the mature, postthymic CD8(+) T cell is to respond to microbial antigens with a developmental program of clonal expansion and concomitant differentiation leading to effector cells (T(EFF)) that provide antimicrobial defense. Because many microbial infections persist into a chronic phase, this antigen-stimulated developmental program must be capable of continually generating T(EFF), perhaps for the lifetime of the individual. This chapter proposes that the ability of a CD8(+) T cell clone to maintain the continual production of T(EFF) during periods of persistent antigenic stimulation is based on a program that has two sequential phases of clonal expansion: an initial stage that occurs mainly in the secondary lymphoid tissues and is mediated by ligation of the T cell receptor (TCR) and CD27, and a subsequent, IL-2-dependent phase that occurs predominantly in peripheral, nonlymphoid tissues. The TCR/CD27-dependent phase establishes a nondifferentiating, self-renewing pool of clonally expanding cells, and the IL-2-dependent phase mediates continued clonal expansion that is coupled to the development of T(EFF). The two pools are linked by the process of asymmetrical division within the self-renewing subset so that, at steady state of cellular replication in this TCR/CD27-dependent subset, one daughter cell remains undifferentiated and the other initiates its commitment to IL-2-dependent terminal differentiation. Superimposed on this basic scheme are a shift in the CD8(+) T cell response to type I and II interferon (IFN) from anti- to pro-proliferative and transcriptional control of replicative senescence by Bmi-1, Blimp-1, and BCL6/BCL6b. This developmental program ensures that despite the occurrence of cellular senescence antiviral CD8(+) T cell clones are maintained for the duration of persistent viral infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981205     DOI: 10.1016/S0065-2776(07)96003-4

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  13 in total

1.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

Review 2.  Histone methyltransferase and histone methylation in inflammatory T-cell responses.

Authors:  Shan He; Qing Tong; Dennis Keith Bishop; Yi Zhang
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

Review 3.  Notch and inflammatory T-cell response: new developments and challenges.

Authors:  Kazuhiro Mochizuki; Shan He; Yi Zhang
Journal:  Immunotherapy       Date:  2011-11       Impact factor: 4.196

4.  Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Rahul Roychoudhuri; David Clever; Alena Gros; Robert L Eil; Eric Tran; Ken-Ichi Hanada; Zhiya Yu; Douglas C Palmer; Sid P Kerkar; Ryan D Michalek; Trevor Upham; Anthony Leonardi; Nicolas Acquavella; Ena Wang; Francesco M Marincola; Luca Gattinoni; Pawel Muranski; Mark S Sundrud; Christopher A Klebanoff; Steven A Rosenberg; Douglas T Fearon; Nicholas P Restifo
Journal:  Cancer Res       Date:  2014-11-28       Impact factor: 12.701

Review 5.  The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy.

Authors:  Ying Wang; Tien Bui; Yi Zhang
Journal:  Int J Hematol       Date:  2022-10-21       Impact factor: 2.319

Review 6.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

7.  CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets.

Authors:  Christopher E Rudd
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

8.  Cell-specific transduction of Prdm1-expressing lineages mediated by a receptor for avian leukosis virus subgroup B.

Authors:  Fotis Asimakopoulos; Harold E Varmus
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  The impact of TCR-binding properties and antigen presentation format on T cell responsiveness.

Authors:  Adam S Chervin; Jennifer D Stone; Phillip D Holler; Ailin Bai; Jianzhu Chen; Herman N Eisen; David M Kranz
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

10.  Immunostimulatory Effects of β-glucan Purified from Paenibacillus polymyxa JB115 on Mouse Splenocytes.

Authors:  Ji-Mi Kim; Hong-Gu Joo
Journal:  Korean J Physiol Pharmacol       Date:  2012-08-10       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.